Early effects of oral administrations of omeplazole with mosapride on intragastric pH

Early effects of oral administrations of omeplazole with mosapride on intragastric pH - Early effects of oral administrations of omeplazole with mosapride on intragastric pH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002082

Enrollment

Registered

2009-07-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Omeplazole 20mg Omeplazole 20 mg with mosapride citrate 5mg

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patient who fills everything the following 1) Helicobacter pylori-negative male Patient 2) Patient of 20 years or more 3) Patient who gives written informed consent

Exclusion criteria

Exclusion criteria: The patient who collides with either the following assumes that it doesn't put it in to the examination 1) Drug allergy 2) Patient who took medicine that influences movement and function of digestive tract such as proton pump inhibitor, H2 blocker, and NSAIDs within 4 weeks

Design outcomes

Primary

Measure	Time frame
intragastric pH by pH meter attached to the antimony pH electrode	—

Countries

Japan

Contacts

Public ContactMasahiko Inamori

Yokohama City University Graduate School of Medicine Gastroenterology Division

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026